Extracorporeal CO2 Removal Market- Overview This report on extracorporeal CO2 removal market studies the current as well as future prospects of the global market.Stakeholders of this report include companies and intermediaries engaged in manufacture, commercialization, and new entrants planning to enter the extracorporeal CO2 removal market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the global extracorporeal CO2 removal market with respect to the leading market segments based on Product, application, access type, end-user, and region.
The global extracorporeal CO2 removal market is divided into five segments: product, application, access type, end-user, and region.Based on product, the market has been further bifurcated into sub-segments extracorporeal CO2 machines and disposables.
The market has been further studied from the point of view of application and access type.Based on application, the market has been divides into chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), bridge to transplant, and others.
Based on end-user, the market has been divided into hospitals, surgical centers, and others.
Each of the market segments have been extensively analyzed based on market-related factors such as rising adoption of minimally invasive ventilation devices.Moreover, historical year-on-year growth has been taken into consideration while estimating the market size.
The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2016 as the base year.
The overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the extracorporeal CO2 removal market and influence it in the near future.Market attractiveness analysis has been provided in the overview section to explain the intensity of competition across different regions.
The competitive scenario among various market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions to strengthen their positions and increase share in the global extracorporeal CO2 removal market.
Based on region, the global extracorporeal CO2 removal market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World.The market size and forecast for each of these regions has been provided for the period between 2016 and 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
The report also provides market size and forecast for major countries in their respective regions.A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities have been provided in the market overview section.
This section of the report also provides market attractiveness analysis, Porter’s five forces analysis, and market share analysis of key players, thus presenting a thorough analysis of the overall competitive scenario in the global extracorporeal CO2 removal market.
Major players operating in the global extracorporeal CO2 removal market are ALung Technologies Inc., XENIOS AG, Medica SPA, ESTOR S.P.A., Medtronic plc, Getinge AB, and Aferetica s.r.l. ALung Technologies Inc. represent the largest geographical outreach with presence in extracorporeal CO2 removal devices.
The global extracorporeal CO2 removal market is segmented as follows:
Global Extracorporeal CO2 removal market Revenue, by Product Extracorporeal CO2 Machines Disposables Gas Exchange Units Access Cannulas
Global Extracorporeal CO2 removal market Revenue, by Application Chronic Obstructive Pulmonary Disease (COPD) Acute Respiratory Distress Syndrome (ARDS) Bridge to Transplant Others
Global Extracorporeal CO2 removal market Revenue, by Access type Venovenous Arteriovenous
Global Extracorporeal CO2 removal market Revenue, by End User Hospital Surgical Centers Others
Global Extracorporeal CO2 removal market Revenue, by Geography North America U.S. Canada Europe Germany U.K. France Italy Spain Rest of Europe Asia Pacific India Japan China Australia & New Zealand Rest of Asia Rest of the World
Our reports have been used by over 10K customers, including:
Hypertension Drug Market Research Report by Analysis (Pulmonary Hypertension Drugs and Systemic Hypertension Drugs), by Therapy (Alpha Blockers, Angiotensin Converting Enzyme Inhibitor, Angiotensin Receptor Blockers, Beta Blockers Vasodilators, and Calcium Channel Blockers), by Distribution - Global Forecast to 2025 - Cumulative Impact...
The global hyperlipidemia drugs market grew at a CAGR of around 3% during 2014-2019. Hyperlipidemia, or high cholesterol, refers to a medical ailment characterized by high levels of fats in the bloodstream. It is the abnormal elevation of lipids and/or lipoprotein levels that can lead to stroke, peripheral vascular...
“TADEKINIG ALFA- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Adult-onset Still’s Disease in 7 Major Markets. A detailed picture of the TADEKINIG ALFA in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and...
Gouty Arthritis (Gout) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis - Pipeline Review, H2 2020, provides an overview of the Gouty Arthritis (Musculoskeletal Disorders) pipeline landscape. Gout is a type of arthritis where swelling...
The Europe kidney disease market is expected to reach US$ 37,311.1 million by 2027 from US$ 23,121.5 million in 2019. The market is estimated to grow with a CAGR of 6.2% from 2020 to 2027. Factors such as increasing incidences of chronic kidney diseases and increase in government expenditure in the healthcare sector are expected to fuel...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Vital Signs Monitoring Market Report The vital signs monitoring devices market by revenue is expected to grow at a CAGR of over 8% during the period 2019–2025. The global vital signs monitoring devices market is expected to grow at an...
Cholesteryl Ester Transfer Protein - Pipeline Review, H2 2020 Summary According to the recently published report ’Cholesteryl Ester Transfer Protein - Pipeline Review, H2 2020’; Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) pipeline Target constitutes close to 7 molecules....
Asthma - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Pipeline Review, H2 2020, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs. These airways,...
House Dust Mite Allergy Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “House Dust Mite Allergy Disease - Global Clinical Trials Review, H2, 2020" provides an overview of House Dust Mite Allergy Clinical trials scenario.This report provides top line data relating...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.